Aptamer Group plc (LON:APTA – Get Free Report) traded up 6.7% during mid-day trading on Tuesday . The company traded as high as GBX 0.85 and last traded at GBX 0.83. 7,801,866 shares were traded during trading, a decline of 51% from the average session volume of 15,890,202 shares. The stock had previously closed at GBX 0.78.
Aptamer Group Stock Performance
The business’s 50-day moving average is GBX 0.88 and its 200-day moving average is GBX 0.70. The company has a market capitalization of £23.25 million, a PE ratio of -6.16 and a beta of -0.52.
Aptamer Group (LON:APTA – Get Free Report) last announced its earnings results on Tuesday, October 14th. The company reported GBX 0.14 earnings per share for the quarter. Aptamer Group had a negative net margin of 343.95% and a negative return on equity of 205.63%.
Aptamer Group Company Profile
Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.
Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.
Featured Articles
- Five stocks we like better than Aptamer Group
- Why Are These Companies Considered Blue Chips?
- Paramount Threw a Wrench in Netflix’s Bid to Acquire Warner Bros.
- What is the NASDAQ Stock Exchange?
- 3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Unassuming Evergy Energy: The AI Boost Your Income Portfolio Needs
Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.
